# Daptomycin

NDC: 0409-0120
Generic name: DAPTOMYCIN
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210802

FDA application: NDA210282

## Active ingredients

- DAPTOMYCIN: 350 mg/7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-0120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-0120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1957b6ce-7382-4a7b-bf02-3595948d09c6